Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Anemia
• Chronic Lymphocytic Leukemia
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Myelogenous Leukemia
• Non-hodgkin Lymphoma
• Prolymphocytic Leukemia

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-09-10